Rhythm Pharmaceuticals IncEigentümerstruktur
| Preis (2026-07-29) | 52W Hoch | 52W Tief |
| 106.53 USD | 122,2 USD | 74,5 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 138,8 USD | 8 | 4 | 0 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 68.593.574 | 14,07 | 9,02 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Rhythm Pharmaceuticals Inc
Mitarbeiter 414
Handelsplatz NASDAQ
Ticker Symbol RYTM
IPO Datum 2017-10-05
Adresse 222 Berkeley Street, Boston, MA, United States, 02116
Webseite https://rhythmtx.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Dr. David P. Meeker M.D. | Chairman, President & CEO |
| 2 | Mr. Hunter C. Smith M.B.A. | CFO & Treasurer |
| 3 | Dr. Alastair Garfield Ph.D. | Chief Scientific Officer |
| 4 | Mr. Yann Mazabraud | Executive VP & Head of International |
| 5 | Ms. Jennifer Lee | Executive VP & Head of North America |
| 6 | Mr. Christopher P. German | Corporate Controller & Principal Accounting Officer |
| 7 | Mr. Joseph Shulman | Chief Technical Officer |
| 8 | Mr. David Connolly | Head of Investor Relations & Corporate Communications |
| 9 | Mr. Jim Flaherty | Senior VP & General Counsel |
| 10 | Ms. Sarah Ryan | Vice President of Sales & Marketing |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | RA Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 2 | BlackRock Inc | 0,00% | 0,00 Mio. USD |
| 3 | Vanguard Group Inc | 0,00% | 0,00 Mio. USD |
| 4 | Baker Bros Advisors LP | 0,00% | 0,00 Mio. USD |
| 5 | PRIMECAP Management Company | 0,00% | 0,00 Mio. USD |
| 6 | Vanguard Portfolio Management, LLC | 0,00% | 0,00 Mio. USD |
| 7 | Vanguard Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 8 | Perceptive Advisors LLC | 0,00% | 0,00 Mio. USD |
| 9 | State Street Corp | 0,00% | 0,00 Mio. USD |
| 10 | The Goldman Sachs Group Inc | 0,00% | 0,00 Mio. USD |
| 11 | Westfield Capital Management Company, L.P. | 0,00% | 0,00 Mio. USD |
| 12 | FMR Inc | 0,00% | 0,00 Mio. USD |
| 13 | T. Rowe Price Associates, Inc. | 0,00% | 0,00 Mio. USD |
| 14 | Polar Capital Holdings PLC | 0,00% | 0,00 Mio. USD |
| 15 | JPMorgan Chase & Co | 0,00% | 0,00 Mio. USD |
| 16 | Citadel Advisors Llc | 0,00% | 0,00 Mio. USD |
| 17 | Geode Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 18 | Federated Hermes Inc | 0,00% | 0,00 Mio. USD |
| 19 | Checkpoint Capital LP | 0,00% | 0,00 Mio. USD |
| 20 | Capital Research Global Investors | 0,00% | 0,00 Mio. USD |